Coinbase Global Inc (COIN)vsIDEXX Laboratories Inc (IDXX)
COIN
Coinbase Global Inc
$201.16
+4.25%
FINANCIAL SERVICES · Cap: $50.96B
IDXX
IDEXX Laboratories Inc
$560.11
-2.11%
HEALTHCARE · Cap: $45.14B
Smart Verdict
WallStSmart Research — data-driven comparison
Coinbase Global Inc generates 55% more annual revenue ($6.88B vs $4.45B). IDXX leads profitability with a 24.6% profit margin vs 18.3%. COIN appears more attractively valued with a PEG of 0.78. IDXX earns a higher WallStSmart Score of 63/100 (C+).
COIN
Buy60
out of 100
Grade: C
IDXX
Buy63
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for COIN.
Margin of Safety
-41.2%
Fair Value
$459.52
Current Price
$560.11
$100.59 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 430.6% YoY
Large-cap with strong market position
Growing faster than its price suggests
Every $100 of equity generates 73 in profit
Strong operational efficiency at 31.8%
Keeps 25 of every $100 in revenue as profit
Areas to Watch
Distress zone — elevated risk
Weak financial health signals
Premium valuation, high expectations priced in
Revenue declined 22.2%
Expensive relative to growth rate
Premium valuation, high expectations priced in
Trading at 27.8x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : COIN
The strongest argument for COIN centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 18.3% and operating margin at 11.3%. PEG of 0.78 suggests the stock is reasonably priced for its growth.
Bull Case : IDXX
The strongest argument for IDXX centers on Return on Equity, Operating Margin, Profit Margin. Profitability is solid with margins at 24.6% and operating margin at 31.8%. Revenue growth of 14.3% demonstrates continued momentum.
Bear Case : COIN
The primary concerns for COIN are Altman Z-Score, Piotroski F-Score, P/E Ratio. A P/E of 70.9x leaves little room for execution misses.
Bear Case : IDXX
The primary concerns for IDXX are PEG Ratio, P/E Ratio, Price/Book. A P/E of 42.0x leaves little room for execution misses.
Key Dynamics to Monitor
COIN profiles as a declining stock while IDXX is a mature play — different risk/reward profiles.
COIN carries more volatility with a beta of 3.38 — expect wider price swings.
IDXX is growing revenue faster at 14.3% — sustainability is the question.
IDXX generates stronger free cash flow (232M), providing more financial flexibility.
Bottom Line
IDXX scores higher overall (63/100 vs 60/100), backed by strong 24.6% margins and 14.3% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Coinbase Global Inc
FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA
Coinbase Global, Inc. provides financial infrastructure and technology for the crypto economy. The company is headquartered in Wilmington, Delaware.
Visit Website →IDEXX Laboratories Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
Compare with Other FINANCIAL DATA & STOCK EXCHANGES Stocks
Want to dig deeper into these stocks?